Grace Therapeutics, Inc.
4 private offerings reported to the SEC on Form D since 2016, $32.9M sold in all. Pharma, New Jersey.
- Form D offerings: 4
- Reported sold: $32.9M
- Newest: Aug 11, 2026
- FDA records: Company page
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| Aug 11, 2026 | — | $10.0M | $10.0M | Grace Therapeutics, Inc.Pharma · New Jersey | Not amended | 0001123292-26-001084 |
| Feb 25, 2025 | — | $15.0M | $30.0M | Grace Therapeutics, Inc.Biotech · New Jersey | Not amended | 0001140361-25-005827 |
| Oct 10, 2023 | — | $7.5M | $15.1M | Acasti Pharma Inc.Biotech · Quebec, Canada | Not amended | 0001123292-23-000122 |
| May 25, 2018 | — | $373K | $838K | Acasti Pharma Inc.Biotech · Quebec, Canada | Not amended | 0001209191-18-033239 |
- Ticker
- GRCE
- Business address
- Princeton, NJ
- Incorporated in
- Delaware
- SEC industry
- Pharmaceutical Preparations
- Former names
- Acasti Pharma Inc.
- All SEC filings
- CIK 1444192 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR